Needham initiated coverage of Agilon Health (AGL) with a Hold rating and no price target Agilon is a “prominent” value-based care enabler that works with payors and providers to ease the transition into downside risk for Medicare populations, the analyst tells investors. While the firm believes Agilon is taking the right steps to remedy problems stemming from heightened utilization and data visibility issues, it also believes upside in Agilon shares is limited until visibility improves, the analyst added.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.